Grifols.com Website Review

We use first and third party cookies to enable the browsing through the website and to improve the services by an*lyzing your browsing habits. If you continue browsing the website, you accept its installation and use as aforementioned. You may modify the settings We improve the health and well-being of patients around the world. Read more Four business divisions united by a shared commitment to quality, safety and on-going innovation. We support the development of the scientific community and its research efforts. Take a look at the portfolio of products and therapies currently in development. We strive to cultivate a friendly, diverse and inclusive work environment. Grifols is becoming increasingly global. A diverse team will remain a key component to our future success. Do you want to know more about one of the leading healthcare companies? Here you will find all the information about Grifols and our commitment to improving the health and well-being of people around world. Grifols is a global healthcare company dedicated to improving the health and well-being of people around the world. Established in Barcelona, Spain in 1940, we are an industry leader in the production of plasma-derived medicines, with 20,000 employees As our business continues to grow, we remain committed to a long-term, sustainable and responsible vision. We trace our roots back to 1940 when Dr. Josep Antoni Grífols i Roig founded Laboratorios Grifols in Barcelona, Spain. The patients we serve around the world are able to lead better lives thanks to plasma-derived medicines and donors. Patients inspire the patients with Alpha-1 Antitrypsin Deficiency (AATD) Read more third quarter and boost net profits to Euros 468 million Read more Our business is organized into four divisions: Bioscience, Diagnostic, Hospital and Bio Supplies. We are committed to a long-term vision that creates a sustainable, positive impact on the communities in which we operate. Since the foundation of Grifols, our on-going innovation has helped shape industry standards in the plasma medicines sector.